Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes and Moderate Renal Impairment (Chronic Kidney Disease Stage 3A): The DERIVE Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Paola
Fioretto
MD
,
Stefano
Del Prato
MD
,
John B
Buse
MD, PhD
,
Ronald
Goldenberg
MD
,
Francesco
Giorgino
MD
,
Daniel
Reyner
DrPH
,
Anna Maria
Langkilde
MD
,
C. David
Sj ӧstrӧm
MD
,
Peter
Sartipy
PhD
, Source Type: research
More News: Chronic Kidney Disease | Dapagliflozin | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Forxiga | Obesity | Study | Urology & Nephrology